SA54 Indirect Comparison of Tarlatamab vs. Chemotherapy (CTx) in Patients With Previously Treated, Platinum-Refractory, or Resistant Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Abstract
Authors
Umit Tapan Franziska Dirnberger Sachin Patel Devon Boyne Tommy Lan Jennifer Uyei Jessie Wang seoyoon Cho Lucy DeCosta Ian Bridges